SeerPharma partners with the University of Technology Sydney (UTS) to deliver innovative, university-accredited graduate programs in Good Manufacturing Practice. Practice-based and contemporary, the programs are unique in Australia and the Asia-Pacific region.
Australian biotech company VivaZome Therapeutics has announced that it has been awarded an Australian Government CRC-P grant of $2.18m in support of the project “Enabling Exosome Therapy: Developing an Advanced Manufacturing Process”, with the funds provided under the Advanced Manufacturing Scheme.
Copyright © SeerPharma
